I am very happy to share our article on the characterisation of the MCM/FLExDUX4 mice. We highlighted several changes that could be used as markers of therapeutic efficacy and developed a force test that reflects the movements made in everyday life. #FSHD
doi.org/10.3390/ijms25211137…
Dumonceaux lab retweeted
Happy World FSHD day 2024! Let’s work together to find a cure.
#FSHDDay #FSHD #MD #FSHDUK #WorldFSHDDay #awareness
Virginie Mariot has presented our work on short and long term efficacy of an AAV-shDUX4 in a DUX4 mouse model @FSHDSociety IRC conference in Denver. A lot of very interesting discussions. #FSHD @DNP_ICH
First FSHD UK research team meeting at UCL. When researchers and clinicians meet to pool their strengths to fight FSHD.
Introducing the FSHD UK Research Team
#research #fshd #uk #md #musculardystrophy #clinicaltrials #fshduk
Fantastic talk from Dr Duguez and Dr Rene at the ALS and MND research meeting #ALS @sduguez_lab @UlsterUniMed @ARSLA75
Dumonceaux lab retweeted
📸The Millennium Bridge in Newcastle, UK was lit orange thanks to TREAT-NMD to mark and support World FSHD Day.
Dumonceaux lab retweeted
FSHD UK founder Rajeshri Badiani recently made waves at the IRC with a captivating presentation - covering our history and her tireless endeavours to create UK clinical readiness. Her presentation elevated the profile of FSHD UK within the international research community.#FSHDUK
FSHD congress in Milan
Fantastic talks and posters and great people !
#FSHD
@FSHDSociety
It was very nice to see everybody. Fantastic conference !
Great to be in Milan for #FSHDIRC and to catch up with so many members of @FSHDUKgroup in person
ENMC workshop on FSHD. The paper is published. #FSHD @FSHDEurope
nmd-journal.com/article/S096…
Good to know: morning vaccination is more beneficial than evening vaccination.
Last year, a @SciImmunology review highlighted the benefits of morning vaccination compared with afternoon/evening vaccination in humans.
Learn more: scim.ag/2qh #DayOfImmunology
Fortitude webinar. Up coming clinical trial for #FSHD
If you missed this week’s FORTITUDE webinar, you can watch the recording on our YouTube channel! Amy Halseth, PhD, and Alissa Peters of @aviditybio discussed the new FORTITUDE clinical trial that will test AOC 1020 in the treatment of #FSHD: bit.ly/3k99bRU #CureFSHD
We are hiring ! A post position (18 months in first instance) is open to develop therapeutic approaches for #FSHD is our lab. Get more information here: ucl.ac.uk/work-at-ucl/search…
Opération 1000 chercheurs dans les écoles. Ravie d'avoir fait une intervention au lycée Français Charles de Gaulle devant les élèves de 2nde. Des moments tjrs très enrichissants. #Telethon2022
























